Kevin F. Staveley-O'Carroll, Ph.D.
Affiliations: | 2000 | Johns Hopkins University, Baltimore, MD |
Area:
ImmunologyGoogle:
"Kevin Staveley-O'Carroll"Parents
Sign in to add mentor| Hyam Levitsky | grad student | 2000 | Johns Hopkins | |
| (An examination of the CD4+ T cell's ineffective response to tumor antigen.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Manjunath Y, Porciani D, Mitchem JB, et al. (2020) Tumor-Cell-Macrophage Fusion Cells as Liquid Biomarkers and Tumor Enhancers in Cancer. International Journal of Molecular Sciences. 21 |
| Liu D, Qi X, Manjunath Y, et al. (2018) Sunitinib and Sorafenib Modulating Antitumor Immunity in Hepatocellular Cancer. Journal of Immunology Research and Therapy. 3: 115-123 |
| Li G, Liu D, Kimchi ET, et al. (2018) Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice. Gastroenterology |
| Liu D, Li G, Avella DM, et al. (2017) Sunitinib represses regulatory T cells to overcome immunotolerance in a murine model of hepatocellular cancer. Oncoimmunology. 7: e1372079 |
| Qi X, Lam SS, Liu D, et al. (2016) Development of inCVAX, In situ Cancer Vaccine, and Its Immune Response in Mice with Hepatocellular Cancer. Journal of Clinical & Cellular Immunology. 7 |
| Avella DM, Li G, Schell TD, et al. (2012) Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model. Hepatology (Baltimore, Md.). 55: 141-52 |
| Ryan CM, Staveley-O'Carroll K, Schell TD. (2008) Combined anti-CD40 conditioning and well-timed immunization prolongs CD8+ T cell accumulation and control of established brain tumors. Journal of Immunotherapy (Hagerstown, Md. : 1997). 31: 906-20 |
| Staveley-O'Carroll K, Schell TD, Jimenez M, et al. (2003) In vivo ligation of CD40 enhances priming against the endogenous tumor antigen and promotes CD8+ T cell effector function in SV40 T antigen transgenic mice. Journal of Immunology (Baltimore, Md. : 1950). 171: 697-707 |
| Ewend MG, Thompson RC, Anderson R, et al. (2000) Intracranial paracrine interleukin-2 therapy stimulates prolonged antitumor immunity that extends outside the central nervous system. Journal of Immunotherapy (Hagerstown, Md. : 1997). 23: 438-48 |
| Ruff AL, Guarnieri FG, Staveley-O'Carroll K, et al. (1997) The enhanced immune response to the HIV gp160/LAMP chimeric gene product targeted to the lysosome membrane protein trafficking pathway. The Journal of Biological Chemistry. 272: 8671-8 |